Le Lézard
Classified in: Health
Subject: SVY

Global POC Blood Glucose Monitoring Devices Market 2017-2021 - Growing Adoption of Minimally Invasive and Technologically Superior Products



DUBLIN, October 5, 2017 /PRNewswire/ --

The "Global POC Blood Glucose Monitoring Devices Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global POC blood glucose monitoring devices market to grow at a CAGR of 8.16% during the period 2017-2021.

Global POC Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver in the market is availability of CGMS and SMBG systems for POC blood glucose monitoring. With the increasing cases of diabetes globally, the need for glycemic control and modern diabetes treatment increases. Glucose monitoring is essential to keep sugar levels in check. Monitoring provides the necessary data required for diabetes management decisions related to food intake, insulin dosage, and exercise regimen. POC blood glucose monitoring devices are effective self-management tools for diabetes management.

One trend in the market is growing adoption of minimally invasive and technologically superior products. The increasing use of minimally invasive products for POC blood glucose monitoring will lead to high adoption rate among people globally. Therefore, the paradigm shift toward minimally invasive products such as wearables and screening products will increase the sales of POC blood glucose monitoring devices.

Further, the report states that one challenge in the market is high cost of diabetes management. The POC blood glucose monitoring devices are cost-efficient products. However, the healthcare expenditure for diabetes management increases the cost for the patient which leads to out-of-pocket expenditure. For screening the level of glucose, a patient has to buy a blood glucose monitoring device and an invasive device such as a lancet separately, which increases the expenditure of the individual. Consumable test strips that are used on a daily basis are expensive.

Key vendors

Other prominent vendors

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By End-User

Part 08: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/sgmpp3/global_poc_blood

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets


These press releases may also interest you

at 20:32
As a mother of three, a blood cancer diagnosis four years ago for 36-year-old Emily Dumler was devastating news. Diagnosed with non-Hodgkin's lymphoma, Dumler wound up undergoing six rounds of outpatient chemotherapy. And while doctors thought the...

at 19:30
Today, at LMT Lab Day Chicago 2018 3D Systems , whose technology enables production of the largest number of orthodontic aligners in the world, unveiled the NextDenttm 5100 and 18 new NextDent resins -- bringing the entire NextDent portfolio to 30...

at 19:01
In response to rising healthcare challenges in the UK, the NPL, the UK's National Measurement Institute (NMI), has today announced the launch of MEMPHYS, to address the critical need for early diagnosis and treatment of conditions such as cancer,...

at 18:44
INDIVA Limited (the "Company" or "INDIVA") is pleased to announce that the Company has granted 640,000 incentive stock options (the "Options") to certain employees and consultants. The Options have an exercise price of...

at 17:51
Humber River Hospital has joined forces with SoftBank Robotics America (SBRA) to launch a new pilot program with Pepper the humanoid robot. "While the healthcare sector has talked about this technology for some time...

at 17:30
Boston Scientific Corporation announced the pricing of a public offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due March 1, 2028 under the company's shelf registration statement.  The...




News published on 5 october 2017 at 11:45 and distributed by: